Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for Cellebrite DI (CLBT) over the last 3 years, with Dec 2024 value amounting to $0.09.

  • Cellebrite DI's EPS (Weighted Average and Diluted) rose 219.42% to $0.09 in Q4 2024 from the same period last year, while for Dec 2024 it was -$0.13, marking a year-over-year increase of 70.20%. This contributed to the annual value of -$1.35 for FY2024, which is 213.95% down from last year.
  • According to the latest figures from Q4 2024, Cellebrite DI's EPS (Weighted Average and Diluted) is $0.09, which was up 219.42% from -$0.08 recorded in Q4 2023.
  • In the past 5 years, Cellebrite DI's EPS (Weighted Average and Diluted) registered a high of $0.28 during Q1 2022, and its lowest value of -$0.20 during Q1 2023.
  • In the last 3 years, Cellebrite DI's EPS (Weighted Average and Diluted) had a median value of $0.04 in 2022 and averaged $0.03.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 1,040.36% in 2022, then crashed by 312.64% in 2023.
  • Cellebrite DI's EPS (Weighted Average and Diluted) (Quarterly) stood at $0.05 in 2020, then grew by 2.17% to $0.26 in 2021, then tumbled by 86.10% to $0.04 in 2022, then slumped by 312.64% to -$0.08 in 2023, then spiked by 219.42% to $0.09 in 2024.
  • Its EPS (Weighted Average and Diluted) was $0.09 in Q4 2024, compared to -$0.08 in Q4 2023 and $0.03 in Q3 2023.